课题基金 / 基金详情

项目摘要

项目成果

Lance S Terada的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Patients infected with HIV-1 display marked abnormalities in endothelial morphology and function. Derangements in intimal organization, proliferation, apoptosis, and differentiation are seen in a number of AIDS-related pathologic conditions involving aberrant vascular function and angiogenic behavior. The viral accessory protein Tat has been implicated as a potential endothelial protocytokine, given its ability to ligate endothelial integrins and Vascular Endothelial Growth Factor Receptor-2. While the pro-angiogenic effects of HIV-1 Tat have been closely scrutinized, the signal pathways involved are poorly understood. Studies in the previous funding period showed that Tat caused rapid activation of an endothelial cell NADPH oxidase, leading to downstream INK MAPK activation. During characterization of a key activating subunit of the oxidase, p47phox, in endothelial cells, we found constitutive association of this protein with the endothelial cytoskeleton, suggesting physical targeting of the oxidase to oxidant-sensitive signaling complexes such as those containing tyrosine kinases and phosphatases. A search for p47-binding partners yielded the orphan adapter TRAF4, and the association ofp47phox with TRAF4 appeared necessary for activation of INK by Tat. A secondary screen for TRAF4-interacting proteins yielded the Proline-rich Tyrosine Kinase-2 (Pyk2)scaffold Hic-5. A third screen using an open form ofp47phox as bait revealed an additional protein, Endothelial-derived Gene-1 (EG-1), which may be associated with tumor angiogenesis. We hypothesize that Tat initiates signaling through site-directed production of oxidants to Hic-5 and EG-1-related signaling complexes. The broad objectives of this grant are to further define the nature and significance of Tat dependent oxidant signaling through Hic-5 and EG-1 in endothelial cells.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/onc.2010.326
发表时间: 2010-10-14
期刊: ONCOGENE
影响因子: 8
作者: [Ma, Z., Liu, Z., Wu, R-F, Terada, L. S.]
通讯作者: Terada, L. S.
Tumor cytotoxicity and endothelial Rac inhibition induced by TNP-470 in anaplastic thyroid cancer.
TNP-470 在甲状腺未分化癌中诱导的肿瘤细胞毒性和内皮 Rac 抑制。
DOI: 10.1158/1535-7163.mct-06-0554
发表时间: 2007
期刊: Molecular cancer therapeutics
影响因子: 5.7
作者: [Nahari,Dorit, Satchi-Fainaro,Ronit, Chen,Ming, Mitchell,Ian, Task,LaurieB, Liu,Zijuan, Kihneman,Jason, Carroll,AllisonB, Terada,LanceS, Nwariaku,FiemuE]
通讯作者: Nwariaku,FiemuE
Involvement of TRAF4 in oxidative activation of c-Jun N-terminal kinase.
TRAF4 参与 c-Jun N 末端激酶的氧化激活。
DOI: 10.1074/jbc.m202665200
发表时间: 2002
期刊: The Journal of biological chemistry
影响因子: --
作者: [Xu,YouCheng, Wu,RuFeng, Gu,Ying, Yang,Yih-Sheng, Yang,Meng-Chun, Nwariaku,FiemuE, Terada,LanceS]
通讯作者: Terada,LanceS
DOI: 10.1161/circresaha.108.184382
发表时间: 2008
期刊: Circulation research
影响因子: 20.1
作者: [Terada,LanceS]
通讯作者: Terada,LanceS
11
    (PQ1) Epigenetic effects of the premalignant field
    • 批准号:
      9340107
    • 项目类别:
    • 资助金额:
      $37.27万
    • 财政年份:
      2016
    • 负责人:
      Lance S Terada
    • 依托单位:
    Training Program in Lung Biology and Disease
    • 批准号:
      8118139
    • 项目类别:
    • 资助金额:
      $42.37万
    • 财政年份:
      2009
    • 负责人:
      Lance S Terada
    • 依托单位:
    Training Program in Lung Biology and Disease
    • 批准号:
      7762504
    • 项目类别:
    • 资助金额:
      $20.33万
    • 财政年份:
      2009
    • 负责人:
      Lance S Terada
    • 依托单位:
    Training Program in Lung Biology and Disease
    • 批准号:
      7939620
    • 项目类别:
    • 资助金额:
      $41.93万
    • 财政年份:
      2009
    • 负责人:
      Lance S Terada
    • 依托单位:
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位:
    双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
    • 批准号:
      81670594
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2016
    • 负责人:
      陈昊
    • 依托单位:
    Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
    • 批准号:
      81470791
    • 项目类别:
      面上项目
    • 资助金额:
      73.0万元
    • 批准年份:
      2014
    • 负责人:
      董家鸿
    • 依托单位: